Skip to main content
Clinical Trials/IRCT201208017219N4
IRCT201208017219N4
Completed
Phase 2

A Clinical trial about comparison of novel treatment with Kohl Al-Ethmed and conventional Antibiotic therapy on patients with Blepharitis

Vice chancellor for research, Kerman University of Medical Sciences0 sites32 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Vice chancellor for research, Kerman University of Medical Sciences
Enrollment
32
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Kerman University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • anterior or posterior blepharitis in one or both eyes, recurrent chalazion.
  • Exclusion criteria: allergic blepharitis or conjunctival inflammatory disease, and the other anterior segment diseases of the eyes.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials